Our results elucidated new insights into the dysregulated LUESCC/miR-6785-5p/NRSN2 regulatory axis in the development of ESCC, and unraveled potential diagnostic markers and therapeutic targets for ESCC. The gene discussed is NRSN2; the disease is esophageal squamous cell carcinoma.